{
  "url": "https://openlegislation.uk/misuse-of-drugs-amendment-england-wales-and-scotland-regulations-2016/note",
  "json_url": "https://openlegislation.uk/misuse-of-drugs-amendment-england-wales-and-scotland-regulations-2016/note.json",
  "legislation": "uksi/2016/1125",
  "legislation_title": "The Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2016",
  "legislation_url": "https://openlegislation.uk/misuse-of-drugs-amendment-england-wales-and-scotland-regulations-2016",
  "path": "note",
  "kind": "note",
  "number": null,
  "heading": "Explanatory note",
  "text": "(This note is not part of the Regulations)\nThese Regulations amend the Misuse of Drugs Regulations 2001 (S.I. 2001/3998) (“the Regulations”). The Schedule of the Regulations in which a controlled drug is placed affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed. The controlled drugs placed in Schedule 1 to the Regulations are those subject to the tightest controls.\nRegulation 3 adds a further range of synthetic cannabinoids to Schedule 1 to the Regulations, excluding those synthetic cannabinoids which are already specified at sub-paragraphs (h) to (lc), two other compounds which are already specified in Schedule 2 to the Regulations (clonitazene and etonitazene), and several other compounds that have legitimate medical uses (acemetacin, atorvastatin, bazedoxifene, indometacin, losartan, olmesartan, proglumetacin, telmisartan, viminol and zafirlukast).\nRegulation 4 adds the anabolic steroid known as Dienedione (estra-4, 9-diene-3,17-dione) to Part 2 of Schedule 4 to the Regulations. Controlled drugs placed in Part 2 of Schedule 4 are exempt from the prohibition on importation, exportation and from the prohibition on possession when in the form of a medicinal product.\nAn Impact Assessment will be published alongside the Explanatory Memorandum on the legislation.gov.uk website.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2016/1125/note",
    "retrieved_at": "2026-10-28T23:17:56.524807+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}